ADAR1 Partners, LP
Insider CIK 1758866 · PIRS 10% owner · KROS 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 743,358 | $17.75 | $13.19M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 4,391,237 | $17.75 | $77.94M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | S Sale | 2025-10-15 | 2025-10-15 | 254,669 | $17.75 | $4.52M | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise deriv | 2025-06-20 | 2025-06-24 | 2 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise deriv | 2025-06-20 | 2025-06-24 | 14 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise deriv | 2025-06-20 | 2025-06-24 | 1 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise | 2025-06-20 | 2025-06-24 | 200 | $70.00 | $14.0K | 743,358 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise | 2025-06-20 | 2025-06-24 | 100 | $60.00 | $6.0K | 4,392,637 | SEC↗ |
| KROS Keros Therapeutics, Inc. | X Exercise | 2025-06-20 | 2025-06-24 | 1,400 | $70.00 | $98.0K | 4,391,237 | SEC↗ |
| KROS Keros Therapeutics, Inc. | E Expire deriv | 2025-05-16 | 2025-06-12 | 178 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | E Expire deriv | 2025-05-16 | 2025-06-12 | 300 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | E Expire deriv | 2025-05-16 | 2025-06-12 | 836 | — | $0 | 0 | SEC↗ |
| KROS Keros Therapeutics, Inc. | J Other deriv | 2025-04-09 | 2025-04-11 | 325,000 | — | $0 | 624,333 | SEC↗ |
| KROS Keros Therapeutics, Inc. | J Other deriv | 2025-04-09 | 2025-04-11 | 500,000 | — | $0 | 124,333 | SEC↗ |
| KROS Keros Therapeutics, Inc. | J Other deriv | 2025-04-09 | 2025-04-11 | 74,333 | — | $0 | 50,000 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 74,333 | $10.33 | $767.9K | 4,392,737 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 18,560 | $9.40 | $174.5K | 3,493,404 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 16,365 | $9.40 | $153.8K | 743,558 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 325,000 | $9.86 | $3.20M | 3,818,404 | SEC↗ |
| KROS Keros Therapeutics, Inc. | P Buy | 2025-04-09 | 2025-04-11 | 500,000 | $10.33 | $5.17M | 4,318,404 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2024-08-12 | 2024-08-12 | 2,243 | $15.88 | $35.6K | 129,574 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2024-08-12 | 2024-08-12 | 757 | $15.88 | $12.0K | 15,067 | SEC↗ |
| PIRS PIERIS PHARMACEUTICALS, IN | P Buy | 2024-08-09 | 2024-08-12 | 3,000 | $14.89 | $44.7K | 127,331 | SEC↗ |